Extra-medullary relapse of leukemia following allogeneic bone marrow transplantation

Hematological Oncology

Volumn 17, Issue 2, 1999, Pages 45-52

  Au, W Y ^a   Kwong, Y L ^a   Lie, A K W ^a   Ma, S K ^a   Liang, Raymond ^a,b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

Bone marrow transplantation; Extra medullary disease; Graft versus leukemia effect

Indexed keywords

INTERFERON; INTERLEUKIN 2;

ALLOGENIC BONE MARROW TRANSPLANTATION; BONE MARROW BIOPSY; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CHLOROMA; GRAFT VERSUS LEUKEMIA EFFECT; HUMAN; IMMUNOTHERAPY; INCIDENCE; LEUKEMIA; MULTIMODALITY CANCER THERAPY; MYELOID LEUKEMIA; PRIORITY JOURNAL; PROGNOSIS; REVIEW; TREATMENT FAILURE;

BONE MARROW TRANSPLANTATION; EUROPE; HEMATOPOIESIS, EXTRAMEDULLARY; HUMANS; INCIDENCE; LEUKEMIA; RECURRENCE; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 0032714242     PISSN: 02780232     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1069(199906)17:2<45::AID-HON641>3.0.CO;2-6     Document Type: Review

References (40)

1. Gale RP, Horowitz MM. Graft-versus-leukemia in bone marrow transplantation. The Advisory Committee of the International Bone Marrow Transplant Registry. Bone Marrow Transplant 1990; 6(Suppl 1): 94-97.
2. Smit WM, Rijnbeek M, van Bergen CA, Fibbe WE, Willemze R, Falkenburg JH. T cells recognizing leukemic CD34(+) progenitor cells mediate the antileukemic effect of donor lymphocyte infusions for relapsed chronic myeloid leukemia after allogeneic stem cell transplantation. Proc Natl Acad Sci U.S.A. 1998; 95(17): 10152-10157.
3. Collins RH Jr, Shpilberg O, Drobyski WR et al. Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation. J Clin Oncol 1997; 15(2): 433-444.
4. Dann EJ, Gillis S, Rowe JM. Late relapse following autologous bone marrow transplantation for acute myelogenous leukemia: case report and review of the literature. Leukemia 1995; 9(6): 1072-1074.
5. Byrd JC, Edenfield WJ, Shields DJ, Dawson NA. Extramedullary myeloid cell tumors in acute nonlymphocytic leukemia: a clinical review. J Clin Oncol 1995: 13(7): 1800-1816.
6. Byrd JC, Weiss RB. Recurrent granulocytic sarcoma. An unusual variation of acute myelogenous leukemia associated with 8;21 chromosomal translocation and blast expression of the neural cell adhesion molecule. Cancer 1994; 73(8): 2107-2112.
7. Au WY, Ma SK, Chan AC, Liang R, Lam CC, Kwong YL. Near tetraploidy in three cases of acute myeloid leukemia associated with mediastinal granulocytic sarcoma. Cancer Genet Cytogenet 1998; 102(1): 50-53.
8. Borgmann A., Hartmann R, Schmid H, Klingebiel T, Ebell W, Gobel U et al. Isolated extramedullary relapse in children with acute lymphoblastic leukemia: a comparison between treatment results of chemotherapy and bone marrow transplantation. BFM Relapse Study Group. Bone Marrow Transplant 1995; 15(4): 515-521.
9. Falletta JM, Shuster JJ, Crist WM, Pullen DJ, Borowitz MJ, Wharam M et al. Different patterns of relapse associated with three intensive treatment regimens for pediatric E-rosette positive T-cell leukemia: a Pediatric Oncology Group study. Leukemia 1992; 6(6): 541-546.
10. Bekassy AN, Hermans J, Gorin NC, Gratwohl A. Granulocytic sarcoma after allogeneic bone marrow transplantation: a retrospective European multicenter survey. Acute and Chronic Leukemia Working Parties of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 1996; 17(5): 801-808.
11. Frassoni F, Barrett AJ, Granena A, Ernst P, Garthon G, Kolb HJ et al. Relapse after allogeneic bone marrow transplantation for acute leukaemia: a survey by the E.B.M.T. of 117 cases. Br J Haematol 1988; 70(3): 317-320.
12. Au WY, Lie AKW, Chan ACL, Ma SK, Chan LC, Kwong YL. Extramedullary relapses of leukemia after bone marrow transplantation: a study on chimerism and minimal residual disease. Blood 1998; 92(10): 340b.
13. Koc Y, Miller KB, Schenkein DP, Daoust P, Sprague K, Berkman E. Extramedullary tumors of myeloid blasts in adults as a pattern of relapse following allogeneic bone marrow transplantation. Cancer 1999; 85(3): 608-615.
14. Simpson DR, Nevill TJ, Shepherd JD, Fung HC, Horsman DE, Nantel SH, et al. High incidence of extramedullary relapse of AML after busulfan/cyclophosphamide conditioning and allogeneic stem cell transplantation. Bone Marrow Transplant 1998; 22(3): 259-264.
15. Mehta J, Powles R, Treleaven J, Horton C, Meller S, Pinkerton CR et al. Outcome of acute leukemia relapsing after bone marrow transplantation: utility of second transplants and adoptive immunotherapy. Bone Marrow Transplant 1997; 19(7): 709-719.
16. Michel G, Boulad F, Small TN, Black P, Heller G, Castro Malaspina H et al. Risk of extramedullary relapse following allogeneic bone marrow transplantation for acute myelogenous leukemia with leukemia cutis. Bone Marrow Transplant 1997; 20(2): 107-112.
17. Dekker AW, van't Veer MB, Sizoo W, Haak HL, van der Lelie J, Ossenkoppele G et al. Intensive postremission chemotherapy without maintenance therapy in adults with acute lymphoblastic leukemia. Dutch Hemato-Oncology Research Group. J Clin Oncol 1997; 15(2): 476-482.
18. Singhal S, Powles R, Kulkarni S, Treleaven J, Saso R, Mehta J. Long-term follow-up of relapsed acute leukemia treated with immunotherapy after allogeneic transplantation: the inseparability of graft-versus-host disease and graft-versus-leukemia, and the problem of extramedullary relapse. Leuk Lymphoma 1999; 32(5-6): 505-512.
19. Glass B, Majolino I, Dreger P, Scime R, Santoro A, Vasta S et al. Allogeneic peripheral blood progenitor cells for treatment of relapse after bone marrow transplantation. Bone Marrow Transplant 1997; 20(7): 533-541.
20. Au WY, Chan AC, Lie AK, Chen FE, Liang R, Kwong YL. Recurrent isolated extramedullary relapses as granulocytic sarcomas following allogeneic bone marrow transplantation for acute myeloid leukemia. Bone Marrow Transplant 1998; 21(2): 205-208.
21. Au WY, Chan AC, Lie AK, So JC, Liang R, Kwong YL. Isolated extramedullary relapse after allogeneic bone marrow transplantation for chronic myeloid leukemia. Bone Marrow Transplant 1998; 22(1): 99-102.
22. Riseberg DA, Mulvey KP, Dahut WL, Frame JN, Phares JC. Late extramedullary relapse following bone marrow transplant for AML presenting as acute renal failure and leukemic ascites. Bone Marrow Transplant 1994; 14(6): 1009-1010.
23. Maygarden SJ, Askin FB, Burkes EJ, Jr., McMillan C, Sanders JE. Isolated extramedullary relapse of acute myelogenous leukemia in a tooth. Mod Pathol 1989; 2(1): 59-62.
24. Singhal S, Powles R, Treleaven J, Horton C, Tait D, Meller S et al. Central nervous system relapse after bone marrow transplantation for acute leukemia in first remission. Bone Marrow Transplant 1996; 17(4): 637-641.
25. Steinherz PG, Siegel SE, Bleyer WA, Kersey J, Chard R, Jr., Coccia P et al. Lymphomatous presentation of childhood acute lymphoblastic leukemia. A subgroup at high risk of early treatment failure. Cancer 1991; 68(4): 751-758.
26. Salutari P, Sica S, Micciulli G, Rutella S, Di Mario A, Leone G. Extramedullary relapse after allogeneic bone marrow transplantation plus buffy-coat in two high risk patients. Haematologica 1996; 81(2): 182-185.
27. Viard F, Bilhou Nabera C, Marit G, Durrieu F, Dubus P, Masseron T et al. Infrequent sites of extramedullary relapse after allogeneic bone marrow transplantation. Nouv Rev Fr Hematol 1995; 37(2): 153-157.
28. Preudhomme C, Wattel E, Lai JL, Henic N, Meyer L, Noel MP et al. Good predictive value of combined cytogenetic and molecular follow up in chronic myelogenous leukemia after non T-cell depleted allogeneic bone marrow transplantation: a report on 38 consecutive cases. Leuk Lymphoma 1995; 18(3-4): 265-271.
29. O'Reilly J, Meyer B, Baker D, Herrmann R, Cannell P, Davies J. Correlation of bone marrow minimal residual disease and apparent isolated extramedullary relapse in childhood acute lympho-blastic leukaemia. Leukemia 1995; 9(4): 624-627.
30. Forrest DL, Dalal BI, Naiman SC, Horsman DE, Berry BR, Parslow MI et al. Testicular relapse of acute promyelocytic leukemia after allogeneic BMT. Bone Marrow Transplant 1997; 20(8): 689-690.
31. Kressler E, Oskar A, Konig M, Mann G, Mayer H, Peters C et al. Extramedullary relapse despite graft versus leukemia effect after bone marrow transplantation in a girl with juvenile myelomoncytic leukemia. Leuk Lymph 1999; 33(5-6): 597-600.
32. Au WY, Lie AKW, Lee CK, Liang R, Kwong YL. Extramedullary relapse of acute lymphoblastic leukemia after allogeneic bone marrow transplantation. Bone Marrow Transplant 1999 (in press).
33. Mortimer J, Blinder M, Schulman S, Appelbaum F, Buckner C, Clift R. Relapse of acute leukemia after marrow transplantation: natural history and results of subsequent therapy. J Clin Oncol 1989; 70: 50-57.
34. Fleming DR, Greenwood ME, Garrison J, Geil JD, Romond EH. Lymphocyte infusion for delayed extramedullary relapse of acute leukemia following bone marrow transplantation. Leuk Lymphoma 1996; 21(5-6): 525-528.
35. Slavin S, Naparstek E, Nagler A, Ackerstein A, Samuel S, Kapelushnik J et al. Allogeneic cell therapy with donor peripheral blood cells and recombinant human interleukin-2 to treat leukemia relapse after allogeneic bone marrow transplantation. Blood 1996; 87(6): 2195-2204.
36. Keil F, Haas OA, Fritsch G, Kalhs P, Lechner K, Mannhalter C et al. Donor leukocyte infusion for leukemic relapse after allogeneic marrow transplantation: lack of residual donor hematopoiesis predicts aplasia. Blood 1997; 89(9): 3113-3117.
37. Au W, Lie A, Lee C, Liang R, Kwong Y. Donor lymphocyte infusion induced molecular remission in relapse of acute myeloid leukaemia after bone marrow transplantation. Bone Marrow Transplant 1999; 23: 1201-1203.
38. Tringali S, Vasta S, Scime R, Catania P, Cavallaro AM, Majolino I. Testicular relapse of AML during chronic graft-versus-host disease induced by donor leukocyte infusion. Haematologica 1996; 81(4): 339-342.
39. Sica S, Di Mario A, Salutari P, Rutella S, Chiusolo P, Rumi C et al. Chemotherapy and recombinant human granulocyte colony-stimulating factor primed donor leukocyte infusion for treatment of relapse after allogeneic bone marrow transplantation. Bone Marrow Transplant 1995; 16(3): 483-485.
40. Nachbaur D, Duba HC, Feichtinger H, Kropshofer G, Nussbaumer W, Schwaighofer H et al. Polychemotherapy combined with G-CSF-mobilized donor buffy coat transfusion for granulocytic sarcoma after allogeneic BMT for AML. Bone Marrow Transplant 1997; 19(9): 947-949.